192 related articles for article (PubMed ID: 38473865)
1. The Role of Opioid Receptor Antagonists in Regulation of Blood Pressure and T-Cell Activation in Mice Selected for High Analgesia Induced by Swim Stress.
Skiba D; Jaskuła K; Nawrocka A; Poznański P; Łazarczyk M; Szymański Ł; Żera T; Sacharczuk M; Cudnoch-Jędrzejewska A; Gaciong Z
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473865
[TBL] [Abstract][Full Text] [Related]
2. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Profile of Naldemedine, a Peripherally Acting
Kanemasa T; Koike K; Takase K; Arai T; Nakamura A; Morioka Y; Hasegawa M
J Pharmacol Exp Ther; 2020 Jun; 373(3):438-444. PubMed ID: 32169839
[TBL] [Abstract][Full Text] [Related]
4. Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint.
Nagasaka H; Awad H; Yaksh TL
Anesthesiology; 1996 Oct; 85(4):808-16. PubMed ID: 8873551
[TBL] [Abstract][Full Text] [Related]
5. Delta-opioid receptor antagonism leads to excessive ethanol consumption in mice with enhanced activity of the endogenous opioid system.
Poznanski P; Lesniak A; Korostynski M; Szklarczyk K; Lazarczyk M; Religa P; Bujalska-Zadrozny M; Sadowski B; Sacharczuk M
Neuropharmacology; 2017 May; 118():90-101. PubMed ID: 28322978
[TBL] [Abstract][Full Text] [Related]
6. Central antinociception induced by ketamine is mediated by endogenous opioids and μ- and δ-opioid receptors.
Pacheco Dda F; Romero TR; Duarte ID
Brain Res; 2014 May; 1562():69-75. PubMed ID: 24675031
[TBL] [Abstract][Full Text] [Related]
7. Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates.
Lewanowitsch T; Irvine RJ
Brain Res; 2003 Feb; 964(2):302-5. PubMed ID: 12576191
[TBL] [Abstract][Full Text] [Related]
8. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.
Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703
[TBL] [Abstract][Full Text] [Related]
10. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
[TBL] [Abstract][Full Text] [Related]
11. Subclass opioid receptors associated with the cardiovascular depression after traumatic shock and the antishock effects of its specific receptor antagonists.
Liu LM; Hu DY; Pan XK; Lu RQ; Dan FJ
Shock; 2005 Nov; 24(5):470-5. PubMed ID: 16247334
[TBL] [Abstract][Full Text] [Related]
12. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
13. Central effects of opioid agonists and naloxone on blood pressure and heart rate in normotensive and hypertensive rats.
Sun SY; Liu Z; Li P; Ingenito AJ
Gen Pharmacol; 1996 Oct; 27(7):1187-94. PubMed ID: 8981066
[TBL] [Abstract][Full Text] [Related]
14. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of delta 9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors.
Reche I; Fuentes JA; Ruiz-Gayo M
Eur J Pharmacol; 1996 Dec; 318(1):11-6. PubMed ID: 9007506
[TBL] [Abstract][Full Text] [Related]
16. Naloxone-induced analgesia mediated by central kappa opioid system in chronic inflammatory pain.
Lee GJ; Kim SA; Kim YJ; Oh SB
Brain Res; 2021 Jul; 1762():147445. PubMed ID: 33766518
[TBL] [Abstract][Full Text] [Related]
17. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
18. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.
Podolsky AT; Sandweiss A; Hu J; Bilsky EJ; Cain JP; Kumirov VK; Lee YS; Hruby VJ; Vardanyan RS; Vanderah TW
Life Sci; 2013 Dec; 93(25-26):1010-6. PubMed ID: 24084045
[TBL] [Abstract][Full Text] [Related]
19. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
[TBL] [Abstract][Full Text] [Related]
20. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
